ID SYDC_YEAST Reviewed; 557 AA. AC P04802; D6VXY6; DT 13-AUG-1987, integrated into UniProtKB/Swiss-Prot. DT 23-JAN-2007, sequence version 3. DT 27-MAR-2024, entry version 228. DE RecName: Full=Aspartate--tRNA ligase, cytoplasmic; DE EC=6.1.1.12; DE AltName: Full=Aspartyl-tRNA synthetase; DE Short=AspRS; GN Name=DPS1; Synonyms=APS, APS1; OrderedLocusNames=YLL018C; GN ORFNames=L1295; OS Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast). OC Eukaryota; Fungi; Dikarya; Ascomycota; Saccharomycotina; Saccharomycetes; OC Saccharomycetales; Saccharomycetaceae; Saccharomyces. OX NCBI_TaxID=559292; RN [1] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA]. RC STRAIN=ATCC 204508 / S288c; RX PubMed=3278298; DOI=10.1093/nar/16.3.1212; RA Reid G.A.; RT "Sequence polymorphisms in the yeast gene encoding aspartyl tRNA RT synthase."; RL Nucleic Acids Res. 16:1212-1212(1988). RN [2] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA]. RX PubMed=3513127; DOI=10.1093/nar/14.4.1657; RA Sellami M., Fasiolo F., Dirheimer G., Ebel J.-P., Gangloff J.; RT "Nucleotide sequence of the gene coding for yeast cytoplasmic aspartyl-tRNA RT synthetase (APS); mapping of the 5' and 3' termini of AspRS mRNA."; RL Nucleic Acids Res. 14:1657-1666(1986). RN [3] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA]. RC STRAIN=ATCC 204508 / S288c; RX PubMed=9046100; RX DOI=10.1002/(sici)1097-0061(199702)13:2<183::aid-yea65>3.0.co;2-v; RA Purnelle B., Goffeau A.; RT "The sequence of 32kb on the left arm of yeast chromosome XII reveals six RT known genes, a new member of the seripauperins family and a new ABC RT transporter homologous to the human multidrug resistance protein."; RL Yeast 13:183-188(1997). RN [4] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RC STRAIN=ATCC 204508 / S288c; RX PubMed=9169871; RA Johnston M., Hillier L.W., Riles L., Albermann K., Andre B., Ansorge W., RA Benes V., Brueckner M., Delius H., Dubois E., Duesterhoeft A., RA Entian K.-D., Floeth M., Goffeau A., Hebling U., Heumann K., RA Heuss-Neitzel D., Hilbert H., Hilger F., Kleine K., Koetter P., Louis E.J., RA Messenguy F., Mewes H.-W., Miosga T., Moestl D., Mueller-Auer S., RA Nentwich U., Obermaier B., Piravandi E., Pohl T.M., Portetelle D., RA Purnelle B., Rechmann S., Rieger M., Rinke M., Rose M., Scharfe M., RA Scherens B., Scholler P., Schwager C., Schwarz S., Underwood A.P., RA Urrestarazu L.A., Vandenbol M., Verhasselt P., Vierendeels F., Voet M., RA Volckaert G., Voss H., Wambutt R., Wedler E., Wedler H., Zimmermann F.K., RA Zollner A., Hani J., Hoheisel J.D.; RT "The nucleotide sequence of Saccharomyces cerevisiae chromosome XII."; RL Nature 387:87-90(1997). RN [5] RP GENOME REANNOTATION. RC STRAIN=ATCC 204508 / S288c; RX PubMed=24374639; DOI=10.1534/g3.113.008995; RA Engel S.R., Dietrich F.S., Fisk D.G., Binkley G., Balakrishnan R., RA Costanzo M.C., Dwight S.S., Hitz B.C., Karra K., Nash R.S., Weng S., RA Wong E.D., Lloyd P., Skrzypek M.S., Miyasato S.R., Simison M., Cherry J.M.; RT "The reference genome sequence of Saccharomyces cerevisiae: Then and now."; RL G3 (Bethesda) 4:389-398(2014). RN [6] RP PROTEIN SEQUENCE OF 2-557. RX PubMed=3902099; DOI=10.1016/s0300-9084(85)80200-5; RA Amiri I., Mejdoub H., Hounwanou N., Boulanger Y., Reinbolt J.; RT "The complete amino acid sequence of cytoplasmic aspartyl-tRNA synthetase RT from Saccharomyces cerevisiae."; RL Biochimie 67:607-613(1985). RN [7] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-81. RC STRAIN=ATCC 90840 / EAY235 / FY23; RX PubMed=8810043; RX DOI=10.1002/(sici)1097-0061(19960615)12:7<693::aid-yea956>3.0.co;2-g; RA Miosga T., Zimmermann F.K.; RT "Sequence analysis of the CEN12 region of Saccharomyces cerevisiae on a RT 43.7 kb fragment of chromosome XII including an open reading frame RT homologous to the human cystic fibrosis transmembrane conductance regulator RT protein CFTR."; RL Yeast 12:693-708(1996). RN [8] RP PARTIAL PROTEIN SEQUENCE, AND MUTAGENESIS. RX PubMed=2021621; DOI=10.1021/bi00231a026; RA Gasparini S., Vincendon P., Eriani G., Gangloff J., Boulanger Y., RA Reinbolt J., Kern D.; RT "Identification of structurally and functionally important histidine RT residues in cytoplasmic aspartyl-tRNA synthetase from Saccharomyces RT cerevisiae."; RL Biochemistry 30:4284-4289(1991). RN [9] RP MUTAGENESIS OF PRO-273. RX PubMed=8248175; DOI=10.1073/pnas.90.22.10816; RA Eriani G., Cavarelli J., Martin F., Dirheimer G., Moras D., Gangloff J.; RT "Role of dimerization in yeast aspartyl-tRNA synthetase and importance of RT the class II invariant proline."; RL Proc. Natl. Acad. Sci. U.S.A. 90:10816-10820(1993). RN [10] RP ACETYLATION AT SER-2. RX PubMed=9298649; DOI=10.1002/elps.1150180810; RA Garrels J.I., McLaughlin C.S., Warner J.R., Futcher B., Latter G.I., RA Kobayashi R., Schwender B., Volpe T., Anderson D.S., Mesquita-Fuentes R., RA Payne W.E.; RT "Proteome studies of Saccharomyces cerevisiae: identification and RT characterization of abundant proteins."; RL Electrophoresis 18:1347-1360(1997). RN [11] RP LEVEL OF PROTEIN EXPRESSION [LARGE SCALE ANALYSIS]. RX PubMed=14562106; DOI=10.1038/nature02046; RA Ghaemmaghami S., Huh W.-K., Bower K., Howson R.W., Belle A., Dephoure N., RA O'Shea E.K., Weissman J.S.; RT "Global analysis of protein expression in yeast."; RL Nature 425:737-741(2003). RN [12] RP PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-301, AND IDENTIFICATION BY RP MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RC STRAIN=ADR376; RX PubMed=17330950; DOI=10.1021/pr060559j; RA Li X., Gerber S.A., Rudner A.D., Beausoleil S.A., Haas W., Villen J., RA Elias J.E., Gygi S.P.; RT "Large-scale phosphorylation analysis of alpha-factor-arrested RT Saccharomyces cerevisiae."; RL J. Proteome Res. 6:1190-1197(2007). RN [13] RP PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-546, AND IDENTIFICATION BY RP MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RX PubMed=17287358; DOI=10.1073/pnas.0607084104; RA Chi A., Huttenhower C., Geer L.Y., Coon J.J., Syka J.E.P., Bai D.L., RA Shabanowitz J., Burke D.J., Troyanskaya O.G., Hunt D.F.; RT "Analysis of phosphorylation sites on proteins from Saccharomyces RT cerevisiae by electron transfer dissociation (ETD) mass spectrometry."; RL Proc. Natl. Acad. Sci. U.S.A. 104:2193-2198(2007). RN [14] RP PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-14; SER-301 AND SER-502, AND RP IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RX PubMed=18407956; DOI=10.1074/mcp.m700468-mcp200; RA Albuquerque C.P., Smolka M.B., Payne S.H., Bafna V., Eng J., Zhou H.; RT "A multidimensional chromatography technology for in-depth phosphoproteome RT analysis."; RL Mol. Cell. Proteomics 7:1389-1396(2008). RN [15] RP PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-301 AND SER-502, AND RP IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RX PubMed=19779198; DOI=10.1126/science.1172867; RA Holt L.J., Tuch B.B., Villen J., Johnson A.D., Gygi S.P., Morgan D.O.; RT "Global analysis of Cdk1 substrate phosphorylation sites provides insights RT into evolution."; RL Science 325:1682-1686(2009). RN [16] RP X-RAY CRYSTALLOGRAPHY (3.0 ANGSTROMS). RX PubMed=2047877; DOI=10.1126/science.2047877; RA Ruff M., Krishnaswamy S., Boeglin M., Poterszman A., Mitschler A., RA Podjarny A., Rees B., Thierry J.-C., Moras D.; RT "Class II aminoacyl transfer RNA synthetases: crystal structure of yeast RT aspartyl-tRNA synthetase complexed with tRNA(Asp)."; RL Science 252:1682-1689(1991). RN [17] RP X-RAY CRYSTALLOGRAPHY (3.0 ANGSTROMS), AND MUTAGENESIS. RX PubMed=8313877; DOI=10.1002/j.1460-2075.1994.tb06265.x; RA Cavarelli J., Eriani G., Rees B., Ruff M., Boeglin M., Mitschler A., RA Martin F., Gangloff J., Thierry J.-C., Moras D.; RT "The active site of yeast aspartyl-tRNA synthetase: structural and RT functional aspects of the aminoacylation reaction."; RL EMBO J. 13:327-337(1994). CC -!- CATALYTIC ACTIVITY: CC Reaction=ATP + L-aspartate + tRNA(Asp) = AMP + diphosphate + L- CC aspartyl-tRNA(Asp); Xref=Rhea:RHEA:19649, Rhea:RHEA-COMP:9660, CC Rhea:RHEA-COMP:9678, ChEBI:CHEBI:29991, ChEBI:CHEBI:30616, CC ChEBI:CHEBI:33019, ChEBI:CHEBI:78442, ChEBI:CHEBI:78516, CC ChEBI:CHEBI:456215; EC=6.1.1.12; CC -!- SUBUNIT: Homodimer. CC -!- SUBCELLULAR LOCATION: Cytoplasm. CC -!- MISCELLANEOUS: Present with 5750 molecules/cell in log phase SD medium. CC {ECO:0000269|PubMed:14562106}. CC -!- SIMILARITY: Belongs to the class-II aminoacyl-tRNA synthetase family. CC Type 2 subfamily. {ECO:0000305}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; X03606; CAA27269.1; -; Genomic_DNA. DR EMBL; X06665; CAA29865.1; -; Genomic_DNA. DR EMBL; X97560; CAA66172.1; -; Genomic_DNA. DR EMBL; Z73123; CAA97464.1; -; Genomic_DNA. DR EMBL; Z73122; CAA97463.1; -; Genomic_DNA. DR EMBL; X91488; CAA62772.1; -; Genomic_DNA. DR EMBL; BK006945; DAA09302.1; -; Genomic_DNA. DR PIR; A23508; SYBYDC. DR RefSeq; NP_013083.1; NM_001181838.1. DR PDB; 1ASY; X-ray; 2.90 A; A/B=68-557. DR PDB; 1ASZ; X-ray; 3.00 A; A/B=68-557. DR PDB; 1EOV; X-ray; 2.30 A; A=71-557. DR PDBsum; 1ASY; -. DR PDBsum; 1ASZ; -. DR PDBsum; 1EOV; -. DR AlphaFoldDB; P04802; -. DR SMR; P04802; -. DR BioGRID; 31235; 152. DR DIP; DIP-4093N; -. DR IntAct; P04802; 17. DR MINT; P04802; -. DR STRING; 4932.YLL018C; -. DR CarbonylDB; P04802; -. DR GlyGen; P04802; 1 site, 1 O-linked glycan (1 site). DR iPTMnet; P04802; -. DR MaxQB; P04802; -. DR PaxDb; 4932-YLL018C; -. DR PeptideAtlas; P04802; -. DR EnsemblFungi; YLL018C_mRNA; YLL018C; YLL018C. DR GeneID; 850643; -. DR KEGG; sce:YLL018C; -. DR AGR; SGD:S000003941; -. DR SGD; S000003941; DPS1. DR VEuPathDB; FungiDB:YLL018C; -. DR eggNOG; KOG0556; Eukaryota. DR GeneTree; ENSGT01030000234618; -. DR HOGENOM; CLU_004553_2_1_1; -. DR InParanoid; P04802; -. DR OMA; WVHEIRD; -. DR OrthoDB; 382728at2759; -. DR BioCyc; YEAST:G3O-32123-MONOMER; -. DR BRENDA; 6.1.1.12; 984. DR SABIO-RK; P04802; -. DR BioGRID-ORCS; 850643; 1 hit in 10 CRISPR screens. DR EvolutionaryTrace; P04802; -. DR PRO; PR:P04802; -. DR Proteomes; UP000002311; Chromosome XII. DR RNAct; P04802; Protein. DR GO; GO:0017101; C:aminoacyl-tRNA synthetase multienzyme complex; IBA:GO_Central. DR GO; GO:0005737; C:cytoplasm; IDA:SGD. DR GO; GO:0005829; C:cytosol; IBA:GO_Central. DR GO; GO:0005634; C:nucleus; IDA:SGD. DR GO; GO:0004815; F:aspartate-tRNA ligase activity; IDA:SGD. DR GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW. DR GO; GO:0003723; F:RNA binding; IDA:SGD. DR GO; GO:0006422; P:aspartyl-tRNA aminoacylation; IDA:SGD. DR CDD; cd04320; AspRS_cyto_N; 1. DR CDD; cd00776; AsxRS_core; 1. DR Gene3D; 2.40.50.140; Nucleic acid-binding proteins; 1. DR HAMAP; MF_02075; Asp_tRNA_synth_type2; 1. DR InterPro; IPR004364; Aa-tRNA-synt_II. DR InterPro; IPR006195; aa-tRNA-synth_II. DR InterPro; IPR045864; aa-tRNA-synth_II/BPL/LPL. DR InterPro; IPR004523; Asp-tRNA_synthase_2. DR InterPro; IPR002312; Asp/Asn-tRNA-synth_IIb. DR InterPro; IPR012340; NA-bd_OB-fold. DR InterPro; IPR004365; NA-bd_OB_tRNA. DR NCBIfam; TIGR00458; aspS_nondisc; 1. DR PANTHER; PTHR43450:SF1; ASPARTATE--TRNA LIGASE, CYTOPLASMIC; 1. DR PANTHER; PTHR43450; ASPARTYL-TRNA SYNTHETASE; 1. DR Pfam; PF00152; tRNA-synt_2; 1. DR Pfam; PF01336; tRNA_anti-codon; 1. DR PRINTS; PR01042; TRNASYNTHASP. DR SUPFAM; SSF55681; Class II aaRS and biotin synthetases; 1. DR SUPFAM; SSF50249; Nucleic acid-binding proteins; 1. DR PROSITE; PS50862; AA_TRNA_LIGASE_II; 1. PE 1: Evidence at protein level; KW 3D-structure; Acetylation; Aminoacyl-tRNA synthetase; ATP-binding; KW Cytoplasm; Direct protein sequencing; Ligase; Nucleotide-binding; KW Phosphoprotein; Protein biosynthesis; Reference proteome. FT INIT_MET 1 FT /note="Removed" FT /evidence="ECO:0000269|PubMed:3902099, FT ECO:0000269|PubMed:9298649" FT CHAIN 2..557 FT /note="Aspartate--tRNA ligase, cytoplasmic" FT /id="PRO_0000111014" FT REGION 1..74 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 303..306 FT /note="Aspartate" FT /evidence="ECO:0000250" FT COMPBIAS 28..71 FT /note="Basic and acidic residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT BINDING 281 FT /ligand="L-aspartate" FT /ligand_id="ChEBI:CHEBI:29991" FT /evidence="ECO:0000250" FT BINDING 325..327 FT /ligand="ATP" FT /ligand_id="ChEBI:CHEBI:30616" FT /evidence="ECO:0000250" FT BINDING 325 FT /ligand="L-aspartate" FT /ligand_id="ChEBI:CHEBI:29991" FT /evidence="ECO:0000250" FT BINDING 333..335 FT /ligand="ATP" FT /ligand_id="ChEBI:CHEBI:30616" FT /evidence="ECO:0000250" FT BINDING 478 FT /ligand="ATP" FT /ligand_id="ChEBI:CHEBI:30616" FT /evidence="ECO:0000250" FT BINDING 481 FT /ligand="L-aspartate" FT /ligand_id="ChEBI:CHEBI:29991" FT /evidence="ECO:0000250" FT BINDING 485 FT /ligand="L-aspartate" FT /ligand_id="ChEBI:CHEBI:29991" FT /evidence="ECO:0000250" FT BINDING 528..531 FT /ligand="ATP" FT /ligand_id="ChEBI:CHEBI:30616" FT /evidence="ECO:0000250" FT MOD_RES 2 FT /note="N-acetylserine" FT /evidence="ECO:0000269|PubMed:9298649" FT MOD_RES 14 FT /note="Phosphoserine" FT /evidence="ECO:0007744|PubMed:18407956" FT MOD_RES 301 FT /note="Phosphoserine" FT /evidence="ECO:0007744|PubMed:17330950, FT ECO:0007744|PubMed:18407956, ECO:0007744|PubMed:19779198" FT MOD_RES 502 FT /note="Phosphoserine" FT /evidence="ECO:0007744|PubMed:18407956, FT ECO:0007744|PubMed:19779198" FT MOD_RES 546 FT /note="Phosphoserine" FT /evidence="ECO:0007744|PubMed:17287358" FT MUTAGEN 273 FT /note="P->G: Loss of activity; important for dimerization." FT /evidence="ECO:0000269|PubMed:8248175" FT STRAND 73..77 FT /evidence="ECO:0007829|PDB:1EOV" FT HELIX 85..87 FT /evidence="ECO:0007829|PDB:1EOV" FT HELIX 96..98 FT /evidence="ECO:0007829|PDB:1EOV" FT TURN 101..106 FT /evidence="ECO:0007829|PDB:1EOV" FT STRAND 108..120 FT /evidence="ECO:0007829|PDB:1EOV" FT STRAND 122..132 FT /evidence="ECO:0007829|PDB:1EOV" FT STRAND 135..142 FT /evidence="ECO:0007829|PDB:1EOV" FT STRAND 145..149 FT /evidence="ECO:0007829|PDB:1EOV" FT HELIX 151..157 FT /evidence="ECO:0007829|PDB:1EOV" FT STRAND 165..174 FT /evidence="ECO:0007829|PDB:1EOV" FT STRAND 182..198 FT /evidence="ECO:0007829|PDB:1EOV" FT HELIX 208..211 FT /evidence="ECO:0007829|PDB:1EOV" FT HELIX 215..220 FT /evidence="ECO:0007829|PDB:1EOV" FT HELIX 228..233 FT /evidence="ECO:0007829|PDB:1EOV" FT HELIX 235..238 FT /evidence="ECO:0007829|PDB:1EOV" FT HELIX 242..264 FT /evidence="ECO:0007829|PDB:1EOV" FT STRAND 274..278 FT /evidence="ECO:0007829|PDB:1EOV" FT STRAND 280..284 FT /evidence="ECO:0007829|PDB:1EOV" FT STRAND 288..291 FT /evidence="ECO:0007829|PDB:1EOV" FT STRAND 294..298 FT /evidence="ECO:0007829|PDB:1EOV" FT HELIX 303..311 FT /evidence="ECO:0007829|PDB:1EOV" FT STRAND 316..324 FT /evidence="ECO:0007829|PDB:1EOV" FT STRAND 331..333 FT /evidence="ECO:0007829|PDB:1ASZ" FT STRAND 336..346 FT /evidence="ECO:0007829|PDB:1EOV" FT HELIX 352..372 FT /evidence="ECO:0007829|PDB:1EOV" FT HELIX 374..383 FT /evidence="ECO:0007829|PDB:1EOV" FT STRAND 393..395 FT /evidence="ECO:0007829|PDB:1ASY" FT STRAND 398..401 FT /evidence="ECO:0007829|PDB:1EOV" FT HELIX 402..411 FT /evidence="ECO:0007829|PDB:1EOV" FT STRAND 418..420 FT /evidence="ECO:0007829|PDB:1ASY" FT HELIX 424..437 FT /evidence="ECO:0007829|PDB:1EOV" FT STRAND 441..446 FT /evidence="ECO:0007829|PDB:1EOV" FT HELIX 450..452 FT /evidence="ECO:0007829|PDB:1EOV" FT STRAND 461..463 FT /evidence="ECO:0007829|PDB:1ASZ" FT STRAND 466..474 FT /evidence="ECO:0007829|PDB:1EOV" FT STRAND 477..485 FT /evidence="ECO:0007829|PDB:1EOV" FT HELIX 489..498 FT /evidence="ECO:0007829|PDB:1EOV" FT TURN 506..508 FT /evidence="ECO:0007829|PDB:1EOV" FT HELIX 509..515 FT /evidence="ECO:0007829|PDB:1EOV" FT STRAND 522..528 FT /evidence="ECO:0007829|PDB:1EOV" FT HELIX 529..536 FT /evidence="ECO:0007829|PDB:1EOV" FT HELIX 542..545 FT /evidence="ECO:0007829|PDB:1EOV" FT STRAND 546..548 FT /evidence="ECO:0007829|PDB:1ASY" SQ SEQUENCE 557 AA; 63516 MW; 6656279B3E9011A5 CRC64; MSQDENIVKA VEESAEPAQV ILGEDGKPLS KKALKKLQKE QEKQRKKEER ALQLEAEREA REKKAAAEDT AKDNYGKLPL IQSRDSDRTG QKRVKFVDLD EAKDSDKEVL FRARVHNTRQ QGATLAFLTL RQQASLIQGL VKANKEGTIS KNMVKWAGSL NLESIVLVRG IVKKVDEPIK SATVQNLEIH ITKIYTISET PEALPILLED ASRSEAEAEA AGLPVVNLDT RLDYRVIDLR TVTNQAIFRI QAGVCELFRE YLATKKFTEV HTPKLLGAPS EGGSSVFEVT YFKGKAYLAQ SPQFNKQQLI VADFERVYEI GPVFRAENSN THRHMTEFTG LDMEMAFEEH YHEVLDTLSE LFVFIFSELP KRFAHEIELV RKQYPVEEFK LPKDGKMVRL TYKEGIEMLR AAGKEIGDFE DLSTENEKFL GKLVRDKYDT DFYILDKFPL EIRPFYTMPD PANPKYSNSY DFFMRGEEIL SGAQRIHDHA LLQERMKAHG LSPEDPGLKD YCDGFSYGCP PHAGGGIGLE RVVMFYLDLK NIRRASLFPR DPKRLRP //